Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations NYAX Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Strategic Momentum BRBS Q1 2026 Earnings Return to Profitability with Positive EPS of 002 RUM Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Unclear BXP Q1 2026 Earnings Earnings Beat Estimates by Wide Margin Stock Edges Higher H2O America HTO Q1 2026 Earnings EPS Beats Estimates as Stock Edges Higher